In this segment, William Herman, MD, MPH, analyzes Dr Huckfeldt's presentation on glycemic targeting from a health service and clinical research perspective.
In this segment, William Herman, MD, MPH, analyzes Dr Huckfeldt's presentation on glycemic targeting from a health service and clinical research perspective. "There is no one-size-fits-all measure of diabetes quality or glycemic care," said Dr Herman. Dr Herman also discussed his viewpoint as a clinical endocrinologist diabetologist. "So patients who are remarkably likely to have targets I think the targets were appropriately modified based on risk of hypoglycemia," said Herman. "I do have general concern that maybe the targets are even too low based on the evidence."
Exclusive Telemedicine Use Linked to Less Favorable Glycemic Outcomes for T2D Endocrinology Care
December 6th 2023Adults with type 2 diabetes (T2D) undergoing endocrinology care are more likely to experience less favorable hemoglobin A1c improvements if they only use telemedicine compared with patients using in-person care or a mix of both.
Read More
How Can Employers Leverage the DPP to Improve Diabetes Rates?
February 15th 2022On this episode of Managed Care Cast, Jill Hutt, vice president of member services at the Greater Philadelphia Business Coalition on Health, explains the Coalition’s efforts to reduce diabetes rates through the Diabetes Prevention Program (DPP).
Listen
Study Reveals Factors That Further Increase Colorectal Cancer Risk for Adults With T2D
November 14th 2023The strongest associations between diabetes and colorectal cancer risk were observed in participants with a recent diabetes diagnosis and those who had not undergone recent colonoscopy, underscoring the significance of cancer screening.
Read More
Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes
April 22nd 2021The authors of a study in the April 2021 issue of The American Journal of Managed Care® discuss the possible reasons behind the link between care fragmentation and hospitalizations in veterans with diabetes, as well as potential opportunities to address disjointed care in the context of the widespread telehealth uptake seen during the COVID-19 pandemic.
Listen